These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 23419720)
1. Effect of Mst1 overexpression on the growth of human hepatocellular carcinoma HepG2 cells and the sensitivity to cisplatin in vitro. Xu C; Liu C; Huang W; Tu S; Wan F Acta Biochim Biophys Sin (Shanghai); 2013 Apr; 45(4):268-79. PubMed ID: 23419720 [TBL] [Abstract][Full Text] [Related]
2. Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo. Xu CM; Liu WW; Liu CJ; Wen C; Lu HF; Wan FS Cancer Gene Ther; 2013 Aug; 20(8):453-60. PubMed ID: 23928732 [TBL] [Abstract][Full Text] [Related]
3. RASSF1A-mediated regulation of AREG via the Hippo pathway in hepatocellular carcinoma. Ahn EY; Kim JS; Kim GJ; Park YN Mol Cancer Res; 2013 Jul; 11(7):748-58. PubMed ID: 23594797 [TBL] [Abstract][Full Text] [Related]
4. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma. Wong KF; Liu AM; Hong W; Xu Z; Luk JM Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911 [TBL] [Abstract][Full Text] [Related]
5. TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma. Dong Q; Fu L; Zhao Y; Xie C; Li Q; Wang E Oncotarget; 2017 Feb; 8(9):15689-15703. PubMed ID: 28152516 [TBL] [Abstract][Full Text] [Related]
6. Decursin inhibits the growth of HepG2 hepatocellular carcinoma cells via Hippo/YAP signaling pathway. Li J; Wang H; Wang L; Tan R; Zhu M; Zhong X; Zhang Y; Chen B; Wang L Phytother Res; 2018 Dec; 32(12):2456-2465. PubMed ID: 30251417 [TBL] [Abstract][Full Text] [Related]
7. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Zhou D; Conrad C; Xia F; Park JS; Payer B; Yin Y; Lauwers GY; Thasler W; Lee JT; Avruch J; Bardeesy N Cancer Cell; 2009 Nov; 16(5):425-38. PubMed ID: 19878874 [TBL] [Abstract][Full Text] [Related]
8. Morin impedes Yap nuclear translocation and fosters apoptosis through suppression of Wnt/β-catenin and NF-κB signaling in Mst1 overexpressed HepG2 cells. Perumal N; Perumal M; Kannan A; Subramani K; Halagowder D; Sivasithamparam N Exp Cell Res; 2017 Jun; 355(2):124-141. PubMed ID: 28366538 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis. Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820 [TBL] [Abstract][Full Text] [Related]
10. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling. Mana-Capelli S; McCollum D J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805 [TBL] [Abstract][Full Text] [Related]
11. S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation. Cheng JC; Wang EY; Yi Y; Thakur A; Tsai SH; Hoodless PA Mol Cancer Res; 2018 Oct; 16(10):1543-1555. PubMed ID: 29903770 [TBL] [Abstract][Full Text] [Related]
12. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases. Adler JJ; Johnson DE; Heller BL; Bringman LR; Ranahan WP; Conwell MD; Sun Y; Hudmon A; Wells CD Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17368-73. PubMed ID: 24101513 [TBL] [Abstract][Full Text] [Related]
13. Berberine induced modulation of PHLPP2-Akt-MST1 kinase signaling is coupled with mitochondrial impairment and hepatoma cell death. Saxena S; Shukla S; Kakkar P Toxicol Appl Pharmacol; 2018 May; 347():92-103. PubMed ID: 29626488 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein. Liu XY; Liu SP; Jiang J; Zhang X; Zhang T Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263 [TBL] [Abstract][Full Text] [Related]
15. YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma. LaQuaglia MJ; Grijalva JL; Mueller KA; Perez-Atayde AR; Kim HB; Sadri-Vakili G; Vakili K Sci Rep; 2016 Sep; 6():30238. PubMed ID: 27605415 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway. Chen M; Wang M; Xu S; Guo X; Jiang J Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204 [TBL] [Abstract][Full Text] [Related]
17. Yes-associated protein regulates the growth of human non-small cell lung cancer in response to matrix stiffness. Yuan Y; Zhong W; Ma G; Zhang B; Tian H Mol Med Rep; 2015 Jun; 11(6):4267-72. PubMed ID: 25607725 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of SSR2 Enhances Hepatocellular Carcinoma Cisplatin Sensitivity via the Hippo Pathway. Ye R; Yin L; Ge Y; Zhu X; Xiao Y; Fang C; Liu Q; Zhang H; Li H; Xie B Front Biosci (Landmark Ed); 2024 Aug; 29(8):299. PubMed ID: 39206890 [TBL] [Abstract][Full Text] [Related]
19. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells. Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells. Ren A; Yan G; You B; Sun J Cancer Res; 2008 Apr; 68(7):2266-74. PubMed ID: 18381433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]